Carmona Martinez, Alfonso <br/><br/>
Immunogenicity and safety of 11- and 12-valent pneumococcal non-typeable Haemophilus influenzae protein D-conjugate vaccines (11vPHiD-CV, 12vPHiD-CV) in infants: Results from a phase II, randomised, multicentre study.  [electronic resource] 

 -  Vaccine  01 2019 
 - 176-186 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1873-2518 
<br/><br/><label>Standard No.: </label>10.1016/j.vaccine.2018.07.023  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Bacterial--blood<br/>Bacterial Proteins--genetics<br/>Carrier Proteins--genetics<br/>Diphtheria-Tetanus-Pertussis Vaccine--administration & dosage<br/>Female<br/>Haemophilus influenzae<br/>Hepatitis B Vaccines--administration & dosage<br/>Humans<br/>Immunization, Secondary<br/>Immunogenicity, Vaccine<br/>Immunoglobulin D--genetics<br/>Infant<br/>Lipoproteins--genetics<br/>Male<br/>Pneumococcal Infections--immunology<br/>Pneumococcal Vaccines--adverse effects<br/>Poliovirus Vaccine, Inactivated--administration & dosage<br/>Serogroup<br/>Streptococcus pneumoniae<br/>Vaccines, Combined--administration & dosage<br/>Vaccines, Conjugate--adverse effects